189 related articles for article (PubMed ID: 36556972)
41. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
Yuan P; Sun M; Zhang J; Zhu X; Shi D
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
[TBL] [Abstract][Full Text] [Related]
42. Detection and Characterization of Flat Aberrant Crypt Foci (Flat ACF) in the Novel A/J Min/+ Mouse.
Sødring M; Gunnes G; Paulsen JE
Anticancer Res; 2016 Jun; 36(6):2745-50. PubMed ID: 27272784
[TBL] [Abstract][Full Text] [Related]
43. Aberrant crypt foci of the colon as precursors of adenoma and cancer.
Takayama T; Katsuki S; Takahashi Y; Ohi M; Nojiri S; Sakamaki S; Kato J; Kogawa K; Miyake H; Niitsu Y
N Engl J Med; 1998 Oct; 339(18):1277-84. PubMed ID: 9791143
[TBL] [Abstract][Full Text] [Related]
44. Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum modulates the formation of aberrant crypt foci, mucin-depleted foci, and cell proliferation on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in Wistar rats.
Mohania D; Kansal VK; Kruzliak P; Kumari A
Rejuvenation Res; 2014 Aug; 17(4):325-33. PubMed ID: 24524423
[TBL] [Abstract][Full Text] [Related]
45. Identification and quantification of aberrant crypt foci and microadenomas in the human colon.
Roncucci L; Stamp D; Medline A; Cullen JB; Bruce WR
Hum Pathol; 1991 Mar; 22(3):287-94. PubMed ID: 1706308
[TBL] [Abstract][Full Text] [Related]
46. Aberrant crypt foci in patients with colorectal cancer.
Roncucci L; Modica S; Pedroni M; Tamassia MG; Ghidoni M; Losi L; Fante R; Di Gregorio C; Manenti A; Gafa L; Ponz de Leon M
Br J Cancer; 1998 Jun; 77(12):2343-8. PubMed ID: 9649156
[TBL] [Abstract][Full Text] [Related]
47. Natural history of aberrant crypt foci. A surgical approach.
Shpitz B; Hay K; Medline A; Bruce WR; Bull SB; Gallinger S; Stern H
Dis Colon Rectum; 1996 Jul; 39(7):763-7. PubMed ID: 8674368
[TBL] [Abstract][Full Text] [Related]
48. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans.
Rudolph RE; Dominitz JA; Lampe JW; Levy L; Qu P; Li SS; Lampe PD; Bronner MP; Potter JD
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):605-8. PubMed ID: 15767337
[TBL] [Abstract][Full Text] [Related]
49. The natural history of aberrant crypt foci.
Schoen RE; Mutch M; Rall C; Dry SM; Seligson D; Umar A; Pinsky P
Gastrointest Endosc; 2008 Jun; 67(7):1097-102. PubMed ID: 18178205
[TBL] [Abstract][Full Text] [Related]
50. Suppressive effect of RAS inhibitor manumycin A on aberrant crypt foci formation in the azoxymethane-induced rat colorectal carcinogenesis model.
Tsuda M; Okamoto K; Muguruma N; Sannomiya K; Nakagawa T; Miyamoto H; Kitamura S; Goji T; Kimura T; Okahisa T; Izumi K; Takayama T
J Gastroenterol Hepatol; 2013 Oct; 28(10):1616-23. PubMed ID: 23730936
[TBL] [Abstract][Full Text] [Related]
51. Aberrant crypt foci in the adenoma prevention with celecoxib trial.
Cho NL; Redston M; Zauber AG; Carothers AM; Hornick J; Wilton A; Sontag S; Nishioka N; Giardiello FM; Saltzman JR; Gostout C; Eagle CJ; Hawk ET; Bertagnolli MM
Cancer Prev Res (Phila); 2008 Jun; 1(1):21-31. PubMed ID: 19138933
[TBL] [Abstract][Full Text] [Related]
52. Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon.
Shpitz B; Bomstein Y; Mekori Y; Cohen R; Kaufman Z; Grankin M; Bernheim J
Am J Surg; 1997 Oct; 174(4):425-30. PubMed ID: 9337168
[TBL] [Abstract][Full Text] [Related]
53. Oncoprotein coexpression in human aberrant crypt foci and minute polypoid lesions of the large bowel.
Shpitz B; Bomstein Y; Shalev M; Liverant S; Kaufman Z; Klein E; Mekori Y; Bernheim J
Anticancer Res; 1999; 19(4B):3361-6. PubMed ID: 10652634
[TBL] [Abstract][Full Text] [Related]
54. Association of visceral fat accumulation and plasma adiponectin with rectal dysplastic aberrant crypt foci in a clinical population.
Takahashi H; Takayama T; Yoneda K; Endo H; Iida H; Sugiyama M; Fujita K; Yoneda M; Inamori M; Abe Y; Saito S; Wada K; Nakagama H; Nakajima A
Cancer Sci; 2009 Jan; 100(1):29-32. PubMed ID: 19018760
[TBL] [Abstract][Full Text] [Related]
55. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa.
Nucci MR; Robinson CR; Longo P; Campbell P; Hamilton SR
Hum Pathol; 1997 Dec; 28(12):1396-407. PubMed ID: 9416697
[TBL] [Abstract][Full Text] [Related]
56. Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats.
Xiao H; Hao X; Simi B; Ju J; Jiang H; Reddy BS; Yang CS
Carcinogenesis; 2008 Jan; 29(1):113-9. PubMed ID: 17893236
[TBL] [Abstract][Full Text] [Related]
57. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
Takayama T; Ohi M; Hayashi T; Miyanishi K; Nobuoka A; Nakajima T; Satoh T; Takimoto R; Kato J; Sakamaki S; Niitsu Y
Gastroenterology; 2001 Sep; 121(3):599-611. PubMed ID: 11522744
[TBL] [Abstract][Full Text] [Related]
58. Abberant crypt foci -- importance in colorectal carcinogenesis and expression of p53 and mdm2: a changing concept.
Das P; Jain D; Vaiphei K; Wig JD
Dig Dis Sci; 2008 Aug; 53(8):2183-8. PubMed ID: 18080767
[TBL] [Abstract][Full Text] [Related]
59. Aberrant crypt foci: what we know and what we need to know.
Gupta AK; Pretlow TP; Schoen RE
Clin Gastroenterol Hepatol; 2007 May; 5(5):526-33. PubMed ID: 17433788
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of Antineoplasic Activity of Zingiber Officinale Essential Oil in the Colorectal Region of Wistar Rats.
Lima DAN; Pelegrini BB; Uechi FAA; Varago RC; Pimenta BB; Kaneshima AMS; Kaneshima EN; Souza PDC; Pedroso RB; Silveira TGV; Becker TCA
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2141-2147. PubMed ID: 32711443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
